Psychedelics and virtual reality: parallels and applications.
Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch
Therapeutic Advances in Psychopharmacology August 14, 2020 DOI: 10.1177/2045125320948356 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Altered states of consciousness Psychedelic-assisted therapy |
| Keywords | Virtual reality Vr Controlled platform Simulate Therapeutic benefits Substances Deeply altering consciousness Self-awareness Psychological insight Mental well-being Accessible avenues |
| Citations | 50 |
| Key points | Proposes that VR may be a useful tool for preparing hallucinogen-naïve participants for sensory distortions in psychedelic states and for optimizing the setting in psychedelic sessions. |
Abstract
Psychedelic drugs and virtual reality (VR) each have the capacity to disrupt the rigidity and limitations of typical conscious experience. This article delineates the parallels among psychedelic and VR states as well as their potential synergistic applications in clinical and recreational settings. Findings indicate that, individually, psychedelics and VR are used in analogous ways to alter sensory experience and evoke awe. They are also both used in tandem with traditional therapies to treat a variety of mood disorders; their shared capacity to transiently alter perspective and disrupt rigid patterns of mental experience may underly their analogous and transdiagnostic therapeutic uses. In terms of their combined applications, a number of recreational users currently utilize psychedelics and VR together to enhance their experience. We propose that VR may be a useful tool for preparing hallucinogen-naïve participants in clinical trials for the sensory distortions experienced in psychedelic states. Given the critical role of "setting" in psychedelic treatment outcomes, we also detail how VR could be used to optimize the environment in psychedelic sessions. Finally, we provide considerations for future studies and detail how advancements in psychedelic and VR research can inform one another. Collectively, this article outlines a number of connections between psychedelics and VR, and, more broadly, is representative of growing scientific interest into the interactions among technology, psychopharmacology, and mental health.
Comparable studies
Other theoretical and historical papers on altered states of consciousness, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Altered States of Consciousness | 1966 | Theoretical or philosophical paper | |
| Functional neuroanatomy of altered states of consciousness: The transient hypofrontality hypothesis | 2003 | Theoretical or philosophical paper | |
| The Psychedelic Mystical Experience in the Human Encounter with Death | 1969 | Theoretical or philosophical paper | |
| A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics | 2022 | Theoretical or philosophical paper | |
| Hypnotic phenomena and altered states of consciousness: a multilevel framework of description and explanation | 2003 | Theoretical or philosophical paper |
Citations in the library
Cited by 30
- Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacology & Translational Science March 5, 2021
- Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective Frontiers in Psychiatry December 17, 2021
- Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics Scientific Reports May 30, 2022
- Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology August 1, 2024
- The Potential Role of Psychedelic Drugs in Mental Health Care of the Future Pharmacopsychiatry May 12, 2021
and 25 more in the library
Cites 47
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 42 more in the library